Ultime notizie per Arvinas (NASDAQ:ARVN) Azioni

ARVINAS INC

Arvinas

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Northeastern States Rank High

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

ARVN

IOVA

Analizziamo le aziende con RSI basso, che potrebbero offrire interessanti opportunità di profitto nel mercato finanziario. Ecco i nomi.

3 titoli del settore sanitario destinati a decollare nel prossimo trimestre

Arvinas Inc

Small Cap Consumer Research analyst Eric Beder reiterates Betterware de Mexico SAPI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWMX#NYSE">BWMX</a>) with a Buy and maintains $22.5 price target.

Price Target

Reiteration

Analyst Ratings

BWMX

Small Cap Consumer Research Reiterates Buy on Betterware de Mexico SAPI, Maintains $22.5 Price Target

Multisensor AI Holdings, Inc. ("Multisensor AI," "Msai" or "The Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>), a Pioneer in Condition-Based Monitoring and Predictive Maintenance Enabling Industry 4.0, Today Announced a New Wide-Ranging Collaboration With Fotric u.s.a. Inc. ("Fotric"). This Relationship Allows Msai to Incorporate Fotric's Advanced Camera Solutions Into All Product Channels, Including Our Cloud-Based Solution, Msai Connect.
FOTRIC has expertise in defect detection, condition monitoring, and safety assurance across industry sectors including manufacturing, chemical processing, metallurgy, Li-ion battery storage, waste management, electric utilities, oil &amp; gas, and building infrastructure. FOTRIC is renowned for its innovative sensing hardware which is sold in more than 50 countries.
MSAI has historically deployed FOTRIC's advanced PMix AcouTherm hardware in its own Inspections Services business and will continue to do so. The broader collaboration announced today deepens the relationship between FOTRIC and MSAI, facilitating the sale of FOTRIC devices through all of MSAI's channels, including the Company's recently launched <a href="https://pr.report/8zmh">webstore</a>. In addition, integrating FOTRIC handheld and fixed-mount sensors into MSAI Connect allows MSAI's customers to select the best sensors for their application from a wider range of choices. Integration into MSAI Connect will also improve the FOTRIC devices' functionality, with anticipated features like historical trend analysis and automated work order generation. In each of these areas of collaboration, the enhanced solutions are expected to support continued growth for both companies.
Peter Baird, MSAI's Chief Commercial Officer ("CCO"), added: "As satisfied customers of FOTRIC, we are excited to deepen our partnership with them, allowing us to drive sustainable growth by selling their sensor equipment directly and by integrating their equipment into our MSAI Connect software platform. FOTRIC is emerging as an industry leader in quality and innovation, and our enterprise customers will be well served by these excellent products."

Contracts

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

Multisensor AI Holdings Enters Into Collaboration With FOTRIC U.S.A To Incorporate FOTRIC's Advanced Camera Solutions Into All Product Channels, Including It's Cloud-Based Solution, MSAI Connect.

Asset Sales

Canadian Pacific Kansas City And Lanco Group/Mi-Jack Sell Panama Canal Railway Company To APM Terminals; Financial Terms Not Disclosed

WIIM

NCNO

NCino shares are trading lower after the company reported a Q4 adjusted EPS miss. Additionally, Piper Sandler and Needham cut their respective price targets on the stock.

<ul>
<li>Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026</li>
<li>Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval for tividenofusp alfa
<ul>
<li>Productive collaboration continues under START for an accelerated development and approval path for DNL126 `</li>
</ul>
</li>
</ul>

Biotech

General

DNLI

Denali Therapeutics Initiates BLA Filing Ror Accelerated Approval Of Tividenofusp Alfa For Treatment Of Hunter Syndrome And Positive Ongoing Interactions With FDA On DNL126 Through START Program

IncQuery Group offers application lifecycle management (ALM) and systems engineering development and consultancy services to global manufacturers and product companies. IncQuery Group helps simplify the product development process by connecting hardware and software engineering systems and enables better collaboration across development teams and more efficient management of product data. The acquisition further expands PTC's deep expertise in ALM, systems engineering, and product lifecycle management (PLM) and support for customers in these areas.
"A top priority for our customers is transforming their engineering and product development processes to develop their products faster with higher quality, all while meeting regulatory and sustainability requirements," said Neil Barua, President and CEO of PTC. "The acquisition of IncQuery Group strengthens our focus on engineering and product development and adds expertise to help accelerate our ALM and PLM portfolio integrations and better support our customers. We welcome the IncQuery Group team to PTC and look forward to their contributions."
"IncQuery Group shares PTC's commitment to transforming digital engineering and product development processes, and we're thrilled to join the team," said István Ráth, Chairman of the Executive Board of IncQuery Group, and Ákos Horváth, Chief Technology Officer of IncQuery Group. "This is an opportunity to support even more of the world's leading manufacturers and product companies with our systems engineering and ALM expertise, as well as help enhance PTC's leading engineering and product development portfolio."
The acquisition continues PTC's momentum in ALM, following the release of its <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4396333-1&amp;h=1981259432&amp;u=https%3A%2F%2Fwww.ptc.com%2Fen%2Fnews%2F2025%2Fptc-launches-codebeamer-3&amp;a=Codebeamer%C2%AE+3.0+ALM+solution">Codebeamer&#xAE; 3.0 ALM solution</a> and the ongoing development of its <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4396333-1&amp;h=3683988971&amp;u=https%3A%2F%2Fwww.ptc.com%2Fen%2Fnews%2F2024%2Fptc-partners-microsoft-volkswagengroup-codebeamer-generative-ai-copilot&amp;a=Codebeamer+AI+offering">Codebeamer AI offering</a>.
&nbsp;

PTC  Announces Acquisition Of IncQuery Group

RVTY

Revvity Receives FDA Approval For Improved Automated Latent Tuberculosis Test

Guidance

UniFirst Sees FY25 Revenue Of $2.422B - $2.432B Vs. $2.430B Est; EPS Of $7.30 - $7.70 Vs. $7.770 Est.

CARY, N.C., April 2, 2025 /PRNewswire/ -- Fathom Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTHM#NASDAQ">FTHM</a>) ("Fathom" or the "Company"),&nbsp;a national, technology-driven, end-to-end real estate services platform&nbsp;integrating residential brokerage, mortgage, title, and SaaS offerings for brokerages and agents, today announced the launch of its highly anticipated Elevate program for Fathom Realty. Elevate is an industry-first initiative designed to help real estate agents significantly scale their businesses through comprehensive marketing, lead generation, transaction support, coaching, and recruiting assistance, Elevate builds upon Fathom's signature agent-centric commission models and delivers a new level of concierge service at a competitive rate.

FTHM

Fathom Holdings Launches Its Elevate Agent Concierge And Growth Program

Needham analyst Joshua Reilly reiterates AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) with a Buy and maintains $25 price target.

AEYE

Needham Reiterates Buy on AudioEye, Maintains $25 Price Target

<h3>Gainers</h3>
<ul>
<li>MoneyHero (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNY#NASDAQ">MNY</a>) stock moved upwards by 12.3% to $0.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $33.1 million. </li>
<li>Emerald Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) stock moved upwards by 10.25% to $4.3. The market value of their outstanding shares is at $860.2 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) stock moved upwards by 8.31% to $0.81. The market value of their outstanding shares is at $8.0 million. </li>
<li>trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) stock increased by 7.15% to $4.79. The market value of their outstanding shares is at $334.9 million. </li>
<li>Haoxi Health Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares rose 6.6% to $1.13. The market value of their outstanding shares is at $3.1 million. </li>
<li>Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) stock increased by 6.29% to $0.26. The company's market cap stands at $4.3 million. As per the press release, Q4 earnings came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Brag House Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>) stock decreased by 17.3% to $1.05 during Wednesday's pre-market session. The company's market cap stands at $11.2 million. </li>
<li>PodcastOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODC#NASDAQ">PODC</a>) stock fell 11.37% to $1.56. The company's market cap stands at $38.8 million. </li>
<li>Trump Media &amp; Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares decreased by 6.72% to $18.9. The market value of their outstanding shares is at $4.1 billion. </li>
<li>WiMi Hologram Cloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) stock fell 6.58% to $0.8. The market value of their outstanding shares is at $78.5 million. </li>
<li>National CineMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCMI#NASDAQ">NCMI</a>) stock fell 5.86% to $5.63. The market value of their outstanding shares is at $535.9 million. </li>
<li>Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) stock decreased by 5.76% to $0.98. The company's market cap stands at $3.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

MITQ

MSGM

NCMI

PODC

TRVG

WIMI

12 Communication Services Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) shares increased by 59.1% to $3.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $8.9 million. </li>
<li>Quoin Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) shares rose 55.48% to $0.33. The company's market cap stands at $6.7 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock moved upwards by 26.21% to $0.52. The company's market cap stands at $2.7 million. </li>
<li>Greenwich LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLSI#NASDAQ">GLSI</a>) shares rose 17.71% to $10.9. The market value of their outstanding shares is at $143.2 million. </li>
<li>Enzo Biochem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENZ#NYSE">ENZ</a>) shares increased by 17.61% to $0.4. The company's market cap stands at $20.9 million. </li>
<li>Curis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRIS#NASDAQ">CRIS</a>) shares increased by 12.8% to $1.65. The market value of their outstanding shares is at $13.9 million. As per the press release, Q4 earnings came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock fell 64.7% to $0.56 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock declined by 46.47% to $0.14. The market value of their outstanding shares is at $1.7 million. </li>
<li>Edgewise Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) stock declined by 30.51% to $13.99. The company's market cap stands at $1.3 billion. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock decreased by 21.44% to $0.64. The company's market cap stands at $7.4 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock decreased by 19.17% to $0.07. The market value of their outstanding shares is at $1.7 million. </li>
<li>Pulmonx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) stock decreased by 16.89% to $5.71. The market value of their outstanding shares is at $227.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRIS

EWTX

GLSI

LUNG

PCSA

PTPI

QNRX

RSLS

SBFM

SYRA

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) stock rose 28.2% to $0.55 during Wednesday's pre-market session. The company's market cap stands at $6.9 million. </li>
<li>TTEC Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEC#NASDAQ">TTEC</a>) shares increased by 26.91% to $4.15. The market value of their outstanding shares is at $198.1 million. </li>
<li>Intercont (Cayman) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCT#NASDAQ">NCT</a>) stock increased by 9.81% to $5.93. The market value of their outstanding shares is at $159.3 million. </li>
<li>Cycurion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) stock moved upwards by 8.28% to $0.54. The company's market cap stands at $6.4 million. </li>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) shares increased by 7.51% to $0.12. The company's market cap stands at $3.3 million. </li>
<li>Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) stock moved upwards by 5.96% to $0.48. The company's market cap stands at $45.7 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares declined by 79.3% to $1.65 during Wednesday's pre-market session. The market value of their outstanding shares is at $157.6 million. </li>
<li>Eve Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVEX#NYSE">EVEX</a>) stock declined by 21.86% to $2.61. The market value of their outstanding shares is at $776.8 million. </li>
<li>Mobile Infrastructure (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) stock declined by 19.73% to $3.46. The market value of their outstanding shares is at $147.3 million. </li>
<li>Lichen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) shares fell 14.92% to $3.65. The market value of their outstanding shares is at $2.1 million. </li>
<li>ESGL Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESGL#NASDAQ">ESGL</a>) shares declined by 12.41% to $1.75. The company's market cap stands at $71.0 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares declined by 10.08% to $0.28. The company's market cap stands at $54.3 million. As per the news, the Q4 earnings report came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Mobile Infrastructure Corporation Common Stock

BEEP

CYCU

EFSH

ESGL

EVEX

LICN

LNZA

TTEC

UGRO

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock moved upwards by 137.3% to $0.06 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. </li>
<li>ON24 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) shares moved upwards by 22.64% to $6.39. The market value of their outstanding shares is at $270.4 million. </li>
<li>Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) stock moved upwards by 22.28% to $6.09. The market value of their outstanding shares is at $169.9 million. </li>
<li>Valens Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLN#NYSE">VLN</a>) shares rose 13.68% to $2.32. The company's market cap stands at $245.1 million. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) shares rose 13.63% to $2.5. The company's market cap stands at $83.8 million. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) shares moved upwards by 12.96% to $0.98. The market value of their outstanding shares is at $31.4 million. The company's, Q4 earnings came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) shares decreased by 33.6% to $18.67 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Kaltura (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTR#NASDAQ">KLTR</a>) stock fell 8.86% to $1.75. The company's market cap stands at $269.7 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) shares fell 8.06% to $0.58. The company's market cap stands at $6.1 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) stock decreased by 7.7% to $1.32. The market value of their outstanding shares is at $1.6 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares fell 7.17% to $20.98. The market value of their outstanding shares is at $209.2 million. </li>
<li>Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) stock fell 5.98% to $6.61. The company's market cap stands at $270.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CXDO

DGLY

KLTR

MLGO

MYSZ

ONTF

SLNH

YAAS

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

UniFirst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) reported quarterly earnings of $1.40 per share which beat the analyst consensus estimate of $1.32 by 6.06 percent. This is a 14.75 percent increase over earnings of $1.22 per share from the same period last year. The company reported quarterly sales of $602.22 million which missed the analyst consensus estimate of $602.81 million by 0.10 percent. This is a 1.95 percent increase over sales of $590.71 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

UniFirst Q2 Adj $1.40 Beats $1.32 Estimate, Sales $602.22M Miss $602.81M Estimate

CNTM

ConnectM Technology Solutions Receives Non-binding Proposal For $1.60 Per Share In Cash

Leerink Partners analyst Andrew Berens upgrades Compass Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPX#NASDAQ">CMPX</a>) from Market Perform to Outperform and raises the price target from $4 to $6.

Upgrades

CMPX

Leerink Partners Upgrades Compass Therapeutics to Outperform, Raises Price Target to $6

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) with a Buy and maintains $28 price target.

PHAT

Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $28 Price Target

CVNA

Carvana Announces Integration Of Auction And Reconditioning 'Megasite' In Central New Jersey To Boost Capacity

Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) has reportedly become the second most shorted&nbsp;in the technology hardware and&nbsp;equipment industry.
What Happened: S3 Partners has found that 22.3% of Super Micro&#8217;s floating shares are shorted, a short interest valued at $3.89 billion. According to Ihor Dusaniwsky, S3&#8217;s Managing Director, short sellers have augmented their positions by 38% this year, incorporating shares worth $1.1 billion, <a href="https://fortune.com/2025/04/01/supermicro-general-counsel-audit-accounting-investigation-short-seller-stock-profit-ai/">reported</a> Fortune
"Shorting SMCI has not been a profitable trade for the full year, but recently it has been very profitable," stated Dusaniwsky. In the past month alone, short sellers have added 10.7 million shares, a 10% increase in total shares shorted. Despite a year-to-date loss of $263 million, short sellers managed to earn $7 million in profits in March, marking an 18.2% return.
Meanwhile, on Monday, Super Micro Computer appointed Yitai Hu as General Counsel &amp; Senior Vice President, Corporate Development, following a board recommendation from an independent investigation into management and accounting practices. The move is part of the company's efforts to improve internal functions and ensure continued compliance. 
See Also: <a href="https://benzinga.com/tech/25/04/44600131/intels-stock-plummeted-50-in-past-12-months-now-the-lip-bu-tan-led-company-is-betting-on-18a-chip-breakthrough-were-freezing-it" target="_blank" rel="noreferrer noopener">Intel&#8217;s Stock Plummeted 50% In Past 12 Months, Now The Lip-Bu Tan-Led Company Is Betting On 18A Chip Breakthrough: &#8216;We&#8217;re Freezing It&#8217;</a>
Why It Matters: Super Micro and CEO Charles Liang are still dealing with the repercussions of their accounting issues, facing multiple lawsuits and investigations from the Department of Justice (DoJ) and the Securities and Exchange Commission (SEC).
Despite the financial challenges, Liang remains hopeful of a turnaround. Super Micro has confirmed its cooperation with the regulators and the company has recently issued financial filings after months of delay, which Liang considers a significant milestone. The firm aims to meet&nbsp;a $40 billion revenue target&nbsp;by 2025. 
Super Micro&#8217;s current predicament comes on the heels of a&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44459593/super-micro-computer-feels-the-heat-from-competitors-customers-supplies-this-analyst-turns-bearish">downgrade</a>&nbsp;from Goldman Sachs in late March. Analyst Michael Ng downgraded the rating for Super Micro Computer from Neutral to Sell, while reducing the price target from $40 to $32. He cited downside risks on valuation, competition, and gross margins as the reasons for the downgrade. This bearish outlook, coupled with the company&#8217;s ongoing accounting issues, has likely contributed to the surge in short interest.
Super Micro Computer stock rose 2.37% to close at $35.05 on Tuesday. The stock lost nearly 17% over the past 6 months.
<ul>
<li>Read Next:&nbsp;<a href="https://benzinga.com/news/25/03/44575557/mark-cuban-says-if-they-replaced-elon-musk-with-him-hes-still-try-to-make-government-smaller-by-cutting-a-lo" target="_blank" rel="noreferrer noopener">Mark Cuban Says, If They Replaced Elon Musk With Him, He&#8217;s Still Try to Make Government Smaller By &#8216;Cutting A Lot Of People&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

AVGO

INTC

SMCI

Super Micro's Short Position Hits Nearly $4 billion Amid 'Very Profitable' Trades In Recent Times: Report

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN

Health Care

Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update

Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025

Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Arvinas to Participate in Upcoming Investor Conferences

Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial

Arvinas Announces Oral Presentation at 2025 International Conference on  Alzheimer's & Parkinson's Diseases

Comments

Arvinas

Notizie

Ultime notizie per Arvinas (NASDAQ:ARVN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO